Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title Sort descending
Grant Type
Focus Area
Country
Application Due Date
New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
Release Date:
Partner: Arvinas
Review Process: Pfizer Internal
Education Oncology All
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Addressing Knowledge Gaps in Aplastic Anemia
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Efforts to Improve Quality of Migraine Medical Care
Release Date:
Partner: The Japanese Headache Society
Review Process: Expert Review Panel
Translation: Japanese (link)
Education Internal Medicine Japan
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Spain
Title Sort descending
Grant Type
Focus Area
Country
Application Due Date
Release Date:
Review Process:
Improving Pediatric ADHD Care – Innovative Implementation of a National Guideline
Release Date:
Reducing the Burden of Cardiovascular Disease in Indonesia
Release Date:
Programs Toward Improving the Quality of Depression Treatment
Release Date:
Quality improvements in the Management of Atopic Dermatitis
Release Date:
Review Process:
Dermatology Fellowship RFP
Release Date:
Dermatology Early Career Investigator Quality Improvement Projects
Release Date:
Review Process:
Improving the Identification and Management of Adult Growth Hormone Deficiency (AGHD)
Release Date:
Strategies to Support Increasing Exercise and Activity in Haemophilia Patients
Release Date:
Improving Patient Care in Inflammatory Bowel Disease (IBD) through Shared Decision-Making
Release Date:
Review Process:
Inflammatory Bowel Disease Fellowships
Release Date:
Improving Health Care Capacity in Immuno-Oncology
Release Date: